UBS Group’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $192K | Buy |
84,914
+18,822
| +28% | +$42.5K | ﹤0.01% | 5507 |
|
2025
Q1 | $176K | Buy |
66,092
+13,750
| +26% | +$36.7K | ﹤0.01% | 5384 |
|
2024
Q4 | $184K | Buy |
52,342
+36,104
| +222% | +$127K | ﹤0.01% | 5297 |
|
2024
Q3 | $77K | Buy |
16,238
+5,788
| +55% | +$27.4K | ﹤0.01% | 5349 |
|
2024
Q2 | $49.1K | Buy |
10,450
+10,448
| +522,400% | +$49.1K | ﹤0.01% | 5559 |
|
2024
Q1 | $9 | Hold |
2
| – | – | ﹤0.01% | 7936 |
|
2023
Q4 | $8 | Sell |
2
-1,257
| -100% | -$5.03K | ﹤0.01% | 7912 |
|
2023
Q3 | $5.41K | Buy |
1,259
+1,093
| +658% | +$4.7K | ﹤0.01% | 6229 |
|
2023
Q2 | $862 | Sell |
166
-560
| -77% | -$2.91K | ﹤0.01% | 6993 |
|
2023
Q1 | $4.94K | Buy |
+726
| New | +$4.94K | ﹤0.01% | 7017 |
|
2022
Q3 | – | Sell |
-1,077
| Closed | -$5K | – | 9154 |
|
2022
Q2 | $5K | Buy |
+1,077
| New | +$5K | ﹤0.01% | 7798 |
|
2022
Q1 | – | Sell |
-80
| Closed | -$1K | – | 9100 |
|
2021
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 8810 |
|
2021
Q3 | $1K | Sell |
80
-509
| -86% | -$6.36K | ﹤0.01% | 7971 |
|
2021
Q2 | $6K | Buy |
+589
| New | +$6K | ﹤0.01% | 7314 |
|
2021
Q1 | – | Sell |
-5,064
| Closed | -$41K | – | 7874 |
|
2020
Q4 | $41K | Buy |
5,064
+3,038
| +150% | +$24.6K | ﹤0.01% | 5355 |
|
2020
Q3 | $17K | Sell |
2,026
-2,571
| -56% | -$21.6K | ﹤0.01% | 5560 |
|
2020
Q2 | $37K | Buy |
4,597
+667
| +17% | +$5.37K | ﹤0.01% | 5273 |
|
2020
Q1 | $26K | Buy |
3,930
+3,164
| +413% | +$20.9K | ﹤0.01% | 5417 |
|
2019
Q4 | $8K | Buy |
766
+603
| +370% | +$6.3K | ﹤0.01% | 6300 |
|
2019
Q3 | $6K | Buy |
+163
| New | +$6K | ﹤0.01% | 6416 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 6940 |
|
2019
Q1 | – | Sell |
-49
| Closed | -$1K | – | 6837 |
|
2018
Q4 | $1K | Sell |
49
-300
| -86% | -$6.12K | ﹤0.01% | 6937 |
|
2018
Q3 | $22K | Buy |
+349
| New | +$22K | ﹤0.01% | 5829 |
|
2018
Q2 | – | Sell |
-41
| Closed | -$10K | – | 6996 |
|
2018
Q1 | $10K | Buy |
41
+39
| +1,950% | +$9.51K | ﹤0.01% | 5958 |
|
2017
Q4 | $1K | Sell |
2
-11
| -85% | -$5.5K | ﹤0.01% | 6704 |
|
2017
Q3 | $5K | Buy |
+13
| New | +$5K | ﹤0.01% | 6278 |
|
2017
Q2 | – | Sell |
-34
| Closed | -$33K | – | 6657 |
|
2017
Q1 | $33K | Buy |
+34
| New | +$33K | ﹤0.01% | 4873 |
|
2016
Q4 | – | Sell |
-39
| Closed | -$43K | – | 6734 |
|
2016
Q3 | $43K | Buy |
39
+34
| +680% | +$37.5K | ﹤0.01% | 4764 |
|
2016
Q2 | $10K | Buy |
5
+3
| +150% | +$6K | ﹤0.01% | 5883 |
|
2016
Q1 | $3K | Sell |
2
-6
| -75% | -$9K | ﹤0.01% | 6300 |
|
2015
Q4 | $21K | Buy |
8
+1
| +14% | +$2.63K | ﹤0.01% | 5521 |
|
2015
Q3 | $35K | Buy |
7
+6
| +600% | +$30K | ﹤0.01% | 4974 |
|
2015
Q2 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 6427 |
|
2015
Q1 | – | Sell |
-1
| Closed | -$5K | – | 6635 |
|
2014
Q4 | $5K | Buy |
+1
| New | +$5K | ﹤0.01% | 6324 |
|